Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis

Status Recruiting

Clinical Trial Summary

the objective of this study is to determine the incidence of peri-implant mucositis in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. An analytical prospective observational study will be carried out, with an initial follow-up of 12 months.

Clinical Trial Description

Introduction: Peri-implant mucositis (PM) is an inflammatory disease induced by the accumulation of bacteria (biofilm) around dental implants, which can be modulated by individual characteristics of the patient, as well as by numerous factors related to a greater accumulation of biofilm in peri-implant tissues. Without correct regular maintenance, this entity can progress to peri-implantitis, a disease in which there is loss of bone supporting the implant. However, the strength of the association of the factors with the appearance of PM remains weak and incidence studies are limited due to their design and methodological inconsistencies. Therefore, the objective of this study is to determine the incidence of PM in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. Material and method: An analytical prospective observational study will be carried out, with an initial follow-up of 12 months. Patients with treated periodontitis and enrolled in periodontal maintenance will be selected, consecutively. They need to have implants placed in the Periodontics Specialist Clinic and are going to be rehabilitated at the UCM School of Dentistry. Peri-implant and periodontal clinical records, radiographic records, demographic variables, patient-based variables, and submucosal microbiological samples will be taken on the day of crown placement and after 6 and 12 months. The calculation of the sample size estimates the need to recruit 227 patients. The results will be analyzed using regression models. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05356806
Study type	Observational
Source	Universidad Complutense de Madrid
Contact	Elena F Figuero, Prof.
Phone	0034913942186
Email	elfiguer@ucm.es
Status	Recruiting
Phase
Start date	January 10, 2022
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05332327` - Comparison of the Accuracy of Different Periodontal Probes for Peri-implant Pocket Registration
Enrolling by invitation	`NCT06063876` - Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty	N/A
Completed	`NCT01941797` - Experimental Peri-implant Mucositis in Humans	N/A
Enrolling by invitation	`NCT05675241` - Characterizing the Inflammation Around Dental Implants
Completed	`NCT04874467` - Influence of Keratinized Mucosa on Dental Implants With Mucositis	N/A
Recruiting	`NCT05906810` - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis	N/A
Enrolling by invitation	`NCT06137846` - Treatment of Peri-implant Mucositis and Supportive Peri-implant Therapy	N/A
Completed	`NCT05945836` - Peri-implant Disease and Prosthetic Cement: Cross-sectional Study
Not yet recruiting	`NCT05897736` - Salivary Minerals in Patients With Peri-implantitis
Recruiting	`NCT04052373` - Peri-implantitis Implantoplasty Treatment	N/A
Completed	`NCT03844035` - Impacts of Oral Irrigation in Patients With Periimplant Mucositis	N/A
Completed	`NCT03533166` - Effects of a 0.03% CHX Mouth Rinse in Peri-implant Mucositis	N/A
Completed	`NCT03693196` - The Effect of Different Dental Implant Surface Characteristics on Immunological and Microbiological Parameters	N/A
Completed	`NCT03421717` - The Effect of Peri-implant Surgery and Chair-side Supportive Post Surgical Peri-implant Therapy	N/A
Completed	`NCT03998865` - Bacterial Microbiota Characterization on Implant-supported PEEK and Titanium Provisional Abutments	N/A
Recruiting	`NCT05592314` - Lnfluence of the Prosthetic Emergence Profile on the Prevalence of Peri-implant Diseases: a Cross Sectional Study
Completed	`NCT04899986` - Chlorhexidine Gel and Peribioma Periogel Use in Peri-implant Mucositis Sites: a Split-mouth Randomized Clinical Trial.	N/A
Recruiting	`NCT04415801` - Effect of Repeated Removal and Re-placement of Abutments Around Dental Implants	N/A
Recruiting	`NCT04283903` - Metabolomic and Proteomic Fingerprinting in Peri-implant Diseases
Completed	`NCT04215432` - Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis — PiM_Inc

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms